Related Experiment Video
Updated: Jul 5, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
[Description of 165 episodes of fungemia: A multicenter study.]
M Sota1, C Ezpeleta, R Cisterna
1Servicio de Microbiología, Hospital de Basurto, Bilbao, Spain.
Unlabelled:
The aim of this article is to describe the main features of fungemia belonged to the Multicenter Study Sepsis Data realised in 34 spanish hospitals. The hospitals were been given a protocol and a software specially designed for this study. 165 episodes of fungemia has been recovered (total: 5,000 episodes of bacteremia). The main results are showed as follows. Sex: male 100 (60.6%); female 65 (39.4%). Areas: medical 64 (38.8%); intensive care unit 48 (29.1%); surgical 39 (23.6%); paediatric 14 (8.5%). Underlying disease: neoplasia 43 (26.1%); HIV infection 28 (16.9%); chronic obtructive pulmonary disease 18 (10.9%); diabetes mellitus and parenteral drug abuse 15 (9.1%) every one. Nosocomial fungemia: 119 (72.1%). Community-acquired fungemia: 42 (25.5%).
Sources:
primary 41 (24.9%); catheter 40 (24.2%); respiratory 23 (13.9%); urinary 17 (10.3%); abdominal 8 (4.9%); skin/soft tissues 4 (4.4%); surgical wound 6 (3.6%). Fungi most often isolated: Candida albicans, 73 isolates (44.2%); Candida parapsilosis, 20 (12.1%); Cryptococcus spp., 12 (7.3%) and Candida glabrata, 6 (3.6%). Polymicrobial fungemia: 19 (11.5%). Fluconazole (54.4%) and amphotericin B (41.9%) were the antifungal agents most often used. Mortality: 33.3%.
Insights
This study analyzed 165 fungemia episodes from 34 Spanish hospitals, finding most cases were nosocomial and predominantly caused by Candida albicans. Mortality reached 33.3%.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Epidemiology
Context:
- Fungal infections (fungemia) pose a significant threat in hospital settings.
- Understanding the epidemiology of fungemia is crucial for effective treatment and prevention strategies.
- This study leverages data from the Multicenter Study Sepsis Data across 34 Spanish hospitals.
Purpose:
- To describe the key features of fungemia cases identified within a large multicenter study.
- To analyze the demographics, origins, causative fungi, and treatment of fungemia episodes.
- To report the overall mortality rate associated with fungemia.
Summary:
- A total of 165 fungemia episodes were analyzed, with a majority (72.1%) being nosocomial.
- Candida albicans was the most frequently isolated fungus (44.2%).
- Commonly affected patient areas included medical (38.8%) and intensive care units (29.1%).
- Neoplasia (26.1%) and HIV infection (16.9%) were prevalent underlying conditions.
- Fluconazole (54.4%) and amphotericin B (41.9%) were the primary antifungal agents used.
- The overall mortality rate for fungemia was 33.3%.
Impact:
- Provides valuable epidemiological data on fungemia in Spain, aiding clinical decision-making.
- Highlights the significant burden of nosocomial fungemia and identifies key risk factors.
- Informs antifungal stewardship and infection control practices in healthcare settings.
Related Concept Videos
Candidiasis
Fungal Phylum Microsporidia
Investigation of Disease Outbreaks
Cryptococcal Meningitis
Fungal Group Zygomycota
